IMPRIMIS PHARMACEUTICALS, INC. (NASDAQ:IMMY) Files An 8 ...
Market Exclusive-May 16, 2017
The Company operates through the business of developing drug therapies ... on developing and dispensing a portfolio of non-proprietary compounded drugs for ...
No comments:
Post a Comment